Chemerin has been proposed as a novel biomarker of insulin resistance related to obesity and T2D, but it was unknown whether the observed associations between chemerin levels and metabolic features are mainly mediated by obesity or occur independently of obesity. The gene discussed is RARRES2; the disease is obesity due to melanocortin 4 receptor deficiency.